Psychotropic medicines to patients with mental retardation;Psykotrope legemidler til personer med psykisk utviklingshemning

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 8, 2007, Pages 1028-1030

  Bygdnes, Anne Marit ^a   Kristiansen, Arve ^a  

^a Voksenhabiliteringsteamet   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DEINSTITUTIONALIZATION; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL HEALTH SERVICE; MIDDLE AGED; PRESCRIPTION; QUESTIONNAIRE; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY MENTAL HEALTH SERVICES; DEINSTITUTIONALIZATION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MENTAL RETARDATION; MIDDLE AGED; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; QUESTIONNAIRES;

EID: 34247498701     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nøttestad JA, Linaker OM. Psychptropic drug use among people with intellectual disability before and after deinstitutionalization. J Intellect Disabil Res 2003; 47: 464-71.
2. Aman MG, Singh NN. A critical appraisal of recent drug research in mental retardation: the Cold-water studies. J Ment Defic Res 1986; 30: 203-16.
3. Martin JE, Agran M. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements. Appl Res Ment Retard 1985; 6: 33-49.
4. Holden B, Gitlesen JP. Psychotropic medication in adults with mental retardation: prevalence and prescription practices. Res Dev Disab 2004; 25: 509-21.
5. Legemiddelforbruket. www.legemiddelforbruk.no/act/doc_11.htm (29.9.2005).
6. Hurley AD. The misdiagnosis of hallucinations and delusions in persons with mental retardation: a neurodevelopmental perspective. Semin Clin Neuropsychiatry 1996; 1: 122-33.
7. Holden B. Analyse og behandling av alvorlege og bizarre øydeleggelsar hos ei kvinne med lett psykisk utvikligshemning. Ei atferdsanalytisk tolking. Diskriminanten 2004; nr. 3 og 4: 3-13.
8. Utredningsserie 5-2000. Utviklingshemmede med alvorlige atferdsavvik og/eller psykiske lidelser. En kartlegging av spesialisthelsetjenestens tilbud og behov. Oslo: Statens helsetilsyn, 2000.
9. Singh NN, Ellis CR, Wechsler H. Psychopharmacoepidemiology of mental retardation: 1966 to 1995. J Child Adolesc Psychopharmacol 1997; 7: 255-66.
10. Linaker O M. Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded. Br J Psychiatry 1990; 156: 525-30.
11. Emerson E. Challenging behaviour. London: Cambridge University Press, 2001.
12. Matson JL, Bamburg JW, Mayville EA et al. Psychopharmacology and mental retardation: a ten-year review (1990-1999). Res Dev Disabil 2000; 21: 263-96.
13. Pyles DAM, Muniz K, Cade A et al. A behavioural diagnostic paradigm for integrating behaviour-analytic and psychopharmacological interventions for people with a dual diagnosis. Res Dev Disabil 1997; 18: 185-214.
14. Molyneux P, Emerson E, Caine A. Prescription of psychotropic medication to people with intellectual disabilities in primary health-care settings. J Appl Res Intellect Disabil 1999; 12: 46-57.
15. Ahmed Z, Fraser W, Kerr MP et al. Reducing antipsychotic medication in people with a learning disability. Br J Psychiatry 2000; 176: 42-6.
16. Bygdnes AM. Tvang. Embla 2004; nr. 2: 26-33.
17. Skifttun Å. Åtferdsavvik/psykiske lidingar hos psykisk utviklingshemma menneske - utfordringar i eit grenseland. I: Skiftun Å, red. Utfordrande åtferd. Oslo: Gyldendal, 1993: 9-20.